Media coverage
3
Media coverage
Title FDA Approval of Topical Berdazimer Gel Announced for Molluscum Contagiosum; The FDA decision on berdazimer gel, 10.3%, represents the second approved treatment for the viral-borne skin disease. Media name/outlet Consultant Live Country/Territory United States Date 5/01/24 Persons Mark Kaufmann Title FDA Approval of Topical Berdazimer Gel Announced for Molluscum Contagiosum Media name/outlet HCP Live Country/Territory United States Date 5/01/24 Persons Mark Kaufmann Title FDA Approves Berdazimer Gel, 10.3% for the Treatment of Molluscum Contagiosum Media name/outlet Dermatology Times Country/Territory United States Date 1/01/24 Persons Mark Kaufmann